{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"selank-chemo-neuropathy","urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/selank-chemo-neuropathy/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"selank-chemo-neuropathy","title":"Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:35.819Z","body_excerpt":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy (CIPN) involves damage to peripheral nerves from agents like taxanes, platinums, and vinca alkaloids. This produces sensory symptoms such as burning pain, tingling, numbness, and loss of proprioception, often in a stocking-glove distribution. Nerve fibers undergo axonal degeneration and demyelination. Inflammatory signaling and oxidative stress contribute to ongoing nerve dysfunction. Chronic stress and heightened anxiety states can amplify pain perception and interfere with sleep, which in turn affects nerve repair processes. The condition persists when degenerative processes outpace any natural regenerative capacity of the nerves.\n\n## Why Selank might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, non-restorative arousal, and anxiety that can worsen perceived neuropathic symptoms.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It may reduce symptom intensity enough to improve daily function and sleep, but it does not address underlying nerve damage or support regeneration. Any benefit trades off symptom control for potential side effects without advancing repair pathways.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank is examined specifically for the anxiety and neurochemistry layer that can compound CIPN symptoms. Gabapentin or pregabalin addresses symptomatic signal suppression. The two operate on separate layers: one potentially supporting neurochemical balance, the other providing temporary signal dampening. No direct interaction data exists for this pairing in CIPN.\n\n## What the evidence actually shows\n\nNo published studies examine Selank in CIPN or chemotherapy-related nerve damage. Human data on Selank come from Russian trials focused on generalized anxiety disorder (GAD). One study of 62 patients compared Selank to medazepam and reported comparable anxiolytic effects on psychometric scales without sedation or dependence. Another small trial of 30 patients noted similar efficacy to benzodiazepines plus some cognitive enhancement. These are tiered human. Rat studies show Selank modulates GABA receptor expression and reduces anxiety-like behaviors in stress models, tiered preclinical. No human or animal data link Selank directly to nerve regeneration, axonal repair, or CIPN models.\n\n## What scientists say\n\nResearchers describe Selank as producing anxiolytic and nootropic effects through influences on GABA_A receptors and possible cytokine modulation. Russian clinical literature notes its use in anxiety disorders with fewer side effects than benzodiazepines. Western reviews highlight the limited number of independent replications and absence of large-scale international RCTs. No statements appear in CIPN guidelines or reviews regarding Selank.\n\n## What people say on Reddit\n\nAnecdotal reports on Reddit discuss Selank mainly for general anxiety or cognitive support, not CIPN. Users describe subjective calm without sedation. No threads specifically tie Selank use to chemotherapy neuropathy symptoms. These remain anecdotal.\n\n## What people say on X\n\nPosts on X mention Selank in contexts of anxiety relief or peptide research. Occasional references note Russian origin and anx","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c2","text":"Human trials show Selank has anxiolytic effects comparable to low-dose benzodiazepines in GAD without sedation or dependence.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the actual human data tier for Selank.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c4","text":"Gabapentinoids show limited and inconsistent evidence for CIPN treatment; no significant benefit in prevention meta-analysis.","tier":"human","weight":0.8,"section":"Why Gabapentin / pregabalin matters for you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s5"],"source_status":"sourced","why_material":"Grades the drug evidence accurately.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c1","text":"No published studies examine Selank in CIPN.","tier":"mechanistic","weight":0.3,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the primary topic.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c3","text":"Rat studies demonstrate Selank modulates GABA_A receptors and reduces anxiety-like behaviors.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Separates preclinical from human evidence.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic, and Noradrenergic Neurotransmission","quote":"Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.","summary":"Russian human and mechanistic data on Selank for anxiety; no CIPN mention.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"caad3ccf8523b4f53cb9bd7eff8fba3ef83ac13bbbfde0d7b9a494697827ba23"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Human trial comparing Selank to medazepam in GAD.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"573b8c519312d6bafbb44d9213f42433cc0b814563ec7e1cc7d1ffafe10a225c"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/25176261/","title":"A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders in non-psychotic patients","quote":"Selank provided significant improvement of life quality in patients without noticeable side effects.","summary":"Additional human anxiety trial data.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"26348f42068830fa59173d6c3f3c29cfbbd0733e33e759be52a1a1879c2909c4"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/","title":"Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats","quote":"Selank has a pronounced anxiolytic activity...","summary":"Preclinical rat anxiety model data.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"99cde01a9beaa79856601f0de1899f1670c462f34ba67396e7e5281d97b42d15"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","summary":"Meta-analysis on gabapentinoids in CIPN.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"0962fe933c4c738df8c1a399c288a14977a10a211f36e690bcb229dee248b695"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic, and Noradrenergic Neurotransmission","quote":"Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.","summary":"Russian human and mechanistic data on Selank for anxiety; no CIPN mention.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"caad3ccf8523b4f53cb9bd7eff8fba3ef83ac13bbbfde0d7b9a494697827ba23"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Human trial comparing Selank to medazepam in GAD.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"573b8c519312d6bafbb44d9213f42433cc0b814563ec7e1cc7d1ffafe10a225c"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/25176261/","title":"A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders in non-psychotic patients","quote":"Selank provided significant improvement of life quality in patients without noticeable side effects.","summary":"Additional human anxiety trial data.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"26348f42068830fa59173d6c3f3c29cfbbd0733e33e759be52a1a1879c2909c4"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/","title":"Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats","quote":"Selank has a pronounced anxiolytic activity...","summary":"Preclinical rat anxiety model data.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"99cde01a9beaa79856601f0de1899f1670c462f34ba67396e7e5281d97b42d15"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","summary":"Meta-analysis on gabapentinoids in CIPN.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"0962fe933c4c738df8c1a399c288a14977a10a211f36e690bcb229dee248b695"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"selank-chemo-neuropathy","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":5,"anecdotal":0,"scientific":5,"user_reports":0,"questions":0,"evidence_ingests":0}}